To evaluate the usefulness of the <sup>75sup>SeHCAT abdominal retention (AR) measurement in the early diagnosis of diarrhea syndrome (DS).
Thirty-seven patients with diarrhea syndrome within the first month of evolution were prospectively evaluated. The <sup>75sup>Se-SeHCAT abdominal retention was measured 4 and 7 days post-administration of 0.01 mCi of <sup>75sup>SeHCAT. The test was performed prior to treatment and at 3 months when the baseline study was positive. The test was considered positive if the RA was <25%at 4<sup>thsup> and <10%on the 7th day. The patients were visited at 3 months. Depending on the response, 3 groups were established: a) complete response: normalization of stool frequency, b) partial response, decrease of frequency or c) no response.
Group A: The AR of <sup>75sup>Se-SEHCAT was normal in 21 patients. Six were diagnosed of colonic diverticulosis, 8 of irritable bowel syndrome, 1 of lymphocytic colitis, 1 of post-gastroenteritis syndrome, 1 of celiac disease and 1 of stenosis of the cardia. Four are still under study. Group B: The AR of <sup>75sup>Se-SEHCAT decreased in 16 patients. All showed abnormal AR at day 7 and all but 1 at day 4. Following administration of cholestyramine resin, 8 (50%) presented partial response and 8 (50%) complete response. At 3 months, AR had increased at day 4 and 9 at day 7.
The measurement of <sup>75sup>SEHCAT abdominal retention allows the early diagnosis of bile acid malabsorption in 43%of the patients with DS. Measurement at 7 days seems more accurate than that at 4 days.